Anixa Biosciences Inc Quarterly Common Stock, Shares Authorized from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Anixa Biosciences Inc quarterly Common Stock, Shares Authorized history and growth rate from Q3 2010 to Q2 2024.
  • Anixa Biosciences Inc Common Stock, Shares Authorized for the quarter ending July 31, 2024 was 100M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 100M 0 0% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 100M 0 0% Apr 30, 2024 10-Q 2024-06-04
Q4 2023 100M 0 0% Jan 31, 2024 10-Q 2024-03-12
Q3 2023 100M 0 0% Oct 31, 2023 10-Q 2024-09-06
Q2 2023 100M 0 0% Jul 31, 2023 10-Q 2023-09-06
Q1 2023 100M 0 0% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 100M 0 0% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 100M 0 0% Oct 31, 2022 10-K 2024-01-16
Q2 2022 100M 0 0% Jul 31, 2022 10-Q 2022-09-09
Q1 2022 100M 0 0% Apr 30, 2022 10-Q 2022-06-10
Q4 2021 100M 0 0% Jan 31, 2022 10-Q 2022-03-11
Q3 2021 100M 0 0% Oct 31, 2021 10-K 2023-01-04
Q2 2021 100M +52M +108% Jul 31, 2021 10-Q 2021-09-01
Q1 2021 100M +52M +108% Apr 30, 2021 10-Q 2021-06-10
Q4 2020 100M +52M +108% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 100M +52M +108% Oct 31, 2020 10-K 2022-01-04
Q2 2020 48M 0 0% Jul 31, 2020 10-Q 2020-09-08
Q1 2020 48M 0 0% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 48M 0 0% Jan 31, 2020 10-Q 2020-03-09
Q3 2019 48M 0 0% Oct 31, 2019 10-K 2021-01-07
Q2 2019 48M 0 0% Jul 31, 2019 10-Q 2019-09-06
Q1 2019 48M 0 0% Apr 30, 2019 10-Q 2019-06-12
Q4 2018 48M +24M +100% Jan 31, 2019 10-Q 2019-03-13
Q3 2018 48M +24M +100% Oct 31, 2018 10-K 2020-01-09
Q2 2018 48M +24M +100% Jul 31, 2018 10-Q 2018-09-07
Q1 2018 48M +24M +100% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 24M 0 0% Jan 31, 2018 10-Q 2018-03-09
Q3 2017 24M 0 0% Oct 31, 2017 10-K 2019-01-11
Q2 2017 24M 0 0% Jul 31, 2017 10-Q 2017-09-08
Q1 2017 24M 0 0% Apr 30, 2017 10-Q 2017-05-26
Q4 2016 24M 0 0% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 24M 0 0% Oct 31, 2016 10-K 2018-01-09
Q2 2016 24M 0 0% Jul 31, 2016 10-Q 2016-08-19
Q1 2016 24M -576M -96% Apr 30, 2016 10-Q 2016-05-20
Q4 2015 24M -576M -96% Jan 31, 2016 10-Q 2016-02-19
Q3 2015 24M 0 0% Oct 31, 2015 10-K/A 2016-12-08
Q2 2015 24M -576M -96% Jul 31, 2015 10-Q 2015-08-18
Q1 2015 600M 0 0% Apr 30, 2015 10-Q 2015-05-22
Q4 2014 600M 0 0% Jan 31, 2015 10-Q 2015-03-09
Q3 2014 24M -576M -96% Oct 31, 2014 10-K 2015-12-23
Q2 2014 600M +300M +100% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 600M +300M +100% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 600M +300M +100% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 600M +360M +150% Oct 31, 2013 10-K 2015-01-29
Q2 2013 300M +60M +25% Jul 31, 2013 10-Q/A 2013-09-20
Q1 2013 300M +60M +25% Apr 30, 2013 10-Q/A 2013-06-19
Q4 2012 300M +60M +25% Jan 31, 2013 10-Q/A 2013-03-25
Q3 2012 240M 0 0% Oct 31, 2012 10-K/A 2014-01-17
Q2 2012 240M 0 0% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 240M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 240M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 240M 0 0% Oct 31, 2011 10-K 2013-01-29
Q2 2011 240M Jul 31, 2011 10-Q/A 2011-10-14
Q3 2010 240M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.